News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,221 Results
Type
Article (46822)
Company Profile (295)
Press Release (674104)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (209275)
Career Advice (2189)
Deals (36019)
Drug Delivery (114)
Drug Development (82365)
Employer Resources (191)
FDA (16359)
Job Trends (15253)
News (352663)
Policy (33257)
Tag
Academia (2744)
Academic (2)
Accelerated approval (5)
Adcomms (23)
Allergies (87)
Alliances (51000)
ALS (92)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (131)
Approvals (16358)
Artificial intelligence (277)
Autoimmune disease (22)
Automation (16)
Bankruptcy (366)
Best Places to Work (11827)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (201)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (281)
Cancer (2292)
Cardiovascular disease (180)
Career advice (1837)
Career pathing (33)
CAR-T (161)
Cell therapy (445)
Cervical cancer (20)
Clinical research (66724)
Collaboration (861)
Company closure (1)
Compensation (534)
Complete response letters (21)
COVID-19 (2669)
CRISPR (42)
C-suite (249)
Cystic fibrosis (101)
Data (2218)
Decentralized trials (2)
Denatured (31)
Depression (44)
Diabetes (272)
Diagnostics (6525)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (123)
Drug pricing (108)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87505)
Editorial (40)
Employer branding (25)
Employer resources (161)
Events (115966)
Executive appointments (741)
FDA (17635)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (778)
Gene editing (109)
Generative AI (22)
Gene therapy (319)
GLP-1 (758)
Government (4570)
Grass and pollen (4)
Guidances (67)
Healthcare (19199)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2814)
Inflammatory bowel disease (142)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (98)
Interviews (345)
IPO (16718)
IRA (42)
Job creations (3842)
Job search strategy (1570)
Kidney cancer (10)
Labor market (41)
Layoffs (490)
Leadership (19)
Legal (8069)
Liver cancer (76)
Lung cancer (328)
Lymphoma (155)
Machine learning (7)
Management (62)
Manufacturing (315)
MASH (69)
Medical device (13533)
Medtech (13538)
Mergers & acquisitions (19847)
Metabolic disorders (709)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1978)
NextGen: Class of 2025 (6717)
Non-profit (4650)
Now hiring (40)
Obesity (383)
Opinion (223)
Ovarian cancer (77)
Pain (90)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (21)
Patents (236)
Patient recruitment (114)
Peanut (48)
People (59307)
Pharmaceutical (71)
Pharmacy benefit managers (18)
Phase I (20788)
Phase II (29368)
Phase III (21886)
Pipeline (1210)
Policy (144)
Postmarket research (2643)
Preclinical (9066)
Press Release (72)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (252)
Rare diseases (386)
Real estate (6229)
Recruiting (72)
Regulatory (22731)
Reports (55)
Research institute (2477)
Resumes & cover letters (374)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (73)
Series A (138)
Series B (87)
Service/supplier (14)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3779)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (40)
The Weekly (33)
Vaccines (718)
Venture capitalists (43)
Weight loss (253)
Women's health (37)
Worklife (18)
Date
Today (70)
Last 7 days (906)
Last 30 days (2620)
Last 365 days (33278)
2025 (10937)
2024 (35952)
2023 (40865)
2022 (51929)
2021 (56503)
2020 (54900)
2019 (47653)
2018 (35937)
2017 (33085)
2016 (32666)
2015 (38770)
2014 (32378)
2013 (27537)
2012 (29798)
2011 (30536)
2010 (29032)
Location
Africa (793)
Alabama (54)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (39531)
Australia (6503)
California (6202)
Canada (2025)
China (531)
Colorado (274)
Connecticut (275)
Delaware (149)
Europe (85941)
Florida (917)
Georgia (215)
Hawaii (1)
Idaho (58)
Illinois (553)
India (27)
Indiana (317)
Iowa (11)
Japan (163)
Kansas (106)
Kentucky (26)
Louisiana (11)
Maine (62)
Maryland (909)
Massachusetts (4648)
Michigan (238)
Minnesota (409)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (65)
New Jersey (1752)
New Mexico (30)
New York (1772)
North Carolina (1011)
North Dakota (9)
Northern California (2703)
Ohio (206)
Oklahoma (14)
Oregon (34)
Pennsylvania (1388)
Puerto Rico (12)
Rhode Island (33)
South America (1171)
South Carolina (23)
South Dakota (1)
Southern California (2323)
Tennessee (102)
Texas (921)
United States (23530)
Utah (185)
Virginia (148)
Washington D.C. (67)
Washington State (559)
West Virginia (3)
Wisconsin (65)
721,221 Results for "exosome sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PranaX Licenses Exosome Technology to Commercialize Stem Cell Exosomes
March 13, 2025
·
3 min read
Press Releases
NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization
February 6, 2025
·
9 min read
Press Releases
PranaX Appoints Phillip Maderia as CEO to Lead Exosome Innovation
March 12, 2025
·
2 min read
Drug Development
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
BioRestorative Therapies, Inc., a clinical stage company focused on stem cell-based therapies, announced its development of a novel exosome-based biologic program targeting obesity.
May 8, 2024
·
5 min read
Press Releases
Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program
March 27, 2025
·
7 min read
Press Releases
Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics
February 20, 2025
·
3 min read
Press Releases
RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
March 12, 2025
·
3 min read
Press Releases
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
April 29, 2025
·
4 min read
Drug Development
Exosome Therapeutics Are Paving a Path to Clinical Readiness
Exosomes show potential to treat myriad conditions, including cancer and inflammation, but experts are divided on whether the therapies are ready for the limelight.
March 4, 2024
·
6 min read
·
Sruthi S. Balakrishnan
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
1 of 72,123
Next
